Afa Crohn RCH France - Aux malades sous Humira : Sachez que depuis novembre 2016 l'Humira 40mg/0,80ml en auto-injection a été remplacé par l'Humira 40mg/0,40ml. Le principe actif et le dosage restent
![Eindhoven, the Netherlands, 12th November 2019. Humira, adalimumab. A man injecting himself in the leg with a pen and a needle to treat psoriasis or c Stock Photo - Alamy Eindhoven, the Netherlands, 12th November 2019. Humira, adalimumab. A man injecting himself in the leg with a pen and a needle to treat psoriasis or c Stock Photo - Alamy](https://c8.alamy.com/zooms/6/d6992d203d93431888c55b55371a0fbc/2ab3rw3.jpg)
Eindhoven, the Netherlands, 12th November 2019. Humira, adalimumab. A man injecting himself in the leg with a pen and a needle to treat psoriasis or c Stock Photo - Alamy
![Components of the adalimumab (HUMIRA ® ) Pen before, during and after... | Download Scientific Diagram Components of the adalimumab (HUMIRA ® ) Pen before, during and after... | Download Scientific Diagram](https://www.researchgate.net/publication/6448439/figure/fig1/AS:601672510357521@1520461313416/Components-of-the-adalimumab-HUMIRA-R-Pen-before-during-and-after-injection.png)
Components of the adalimumab (HUMIRA ® ) Pen before, during and after... | Download Scientific Diagram
![Eindhoven, the Netherlands, 12th November 2019. Humira, adalimumab. A male hand preparing a pen with a needle for a patient to inject themselves with Stock Photo - Alamy Eindhoven, the Netherlands, 12th November 2019. Humira, adalimumab. A male hand preparing a pen with a needle for a patient to inject themselves with Stock Photo - Alamy](https://c8.alamy.com/comp/2AB3RTH/eindhoven-the-netherlands-12th-november-2019-humira-adalimumab-a-male-hand-preparing-a-pen-with-a-needle-for-a-patient-to-inject-themselves-with-2AB3RTH.jpg)
Eindhoven, the Netherlands, 12th November 2019. Humira, adalimumab. A male hand preparing a pen with a needle for a patient to inject themselves with Stock Photo - Alamy
![HUMIRA® (adalimumab), produit d'AbbVie, est le premier et le seul médicament à recevoir l'approbation de Santé Canada pour le traitement de l'hidradénite suppurée modérée ou grave HUMIRA® (adalimumab), produit d'AbbVie, est le premier et le seul médicament à recevoir l'approbation de Santé Canada pour le traitement de l'hidradénite suppurée modérée ou grave](http://photos.newswire.ca/images/20160106_C6828_PHOTO_FR_592574.jpg)
HUMIRA® (adalimumab), produit d'AbbVie, est le premier et le seul médicament à recevoir l'approbation de Santé Canada pour le traitement de l'hidradénite suppurée modérée ou grave
![Eindhoven, the Netherlands, 12th November 2019. Humira, adalimumab. A man injecting himself in the leg with a pen and a needle to treat psoriasis or c Stock Photo - Alamy Eindhoven, the Netherlands, 12th November 2019. Humira, adalimumab. A man injecting himself in the leg with a pen and a needle to treat psoriasis or c Stock Photo - Alamy](https://c8.alamy.com/comp/2AB3RTY/eindhoven-the-netherlands-12th-november-2019-humira-adalimumab-a-man-injecting-himself-in-the-leg-with-a-pen-and-a-needle-to-treat-psoriasis-or-c-2AB3RTY.jpg)
Eindhoven, the Netherlands, 12th November 2019. Humira, adalimumab. A man injecting himself in the leg with a pen and a needle to treat psoriasis or c Stock Photo - Alamy
![Eindhoven, the Netherlands, 12th November 2019. Humira, adalimumab. A male hand holding a pen with a needle for a patient to inject themselves with to Stock Photo - Alamy Eindhoven, the Netherlands, 12th November 2019. Humira, adalimumab. A male hand holding a pen with a needle for a patient to inject themselves with to Stock Photo - Alamy](https://c8.alamy.com/comp/2AB3RT7/eindhoven-the-netherlands-12th-november-2019-humira-adalimumab-a-male-hand-holding-a-pen-with-a-needle-for-a-patient-to-inject-themselves-with-to-2AB3RT7.jpg)